Colgate-Palmolive (CL) Stock Forecast, Price Target & Predictions
CL Stock Forecast
Colgate-Palmolive stock forecast is as follows: an average price target of $90.75 (represents a -16.38% downside from CL’s last price of $108.53) and a rating consensus of 'Buy', based on 18 wall street analysts offering a 1-year stock forecast.
CL Price Target
The average price target for Colgate-Palmolive (CL) is $90.75 based on 1-year price targets from 18 Wall Street analysts in the past 3 months, with a price target range of $107.00 to $80.00. This represents a potential -16.38% downside from CL's last price of $108.53.
CL Analyst Ratings
According to 18 Wall Street analysts, Colgate-Palmolive's rating consensus is 'Buy'. The analyst rating breakdown for CL stock is 0 'Strong Buy' (0.00%), 12 'Buy' (66.67%), 6 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Colgate-Palmolive Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 22, 2024 | Mark Astrachan | Stifel Nicolaus | $105.00 | $98.08 | 7.06% | -3.25% |
| May 28, 2024 | Dara Mohsenian | Morgan Stanley | $103.00 | $93.30 | 10.40% | -5.10% |
| May 15, 2024 | Chris Graja | Argus Research | $107.00 | $94.57 | 13.14% | -1.41% |
| Apr 29, 2024 | Steve Powers | Deutsche Bank | $98.00 | $90.13 | 8.74% | -9.70% |
| Apr 29, 2024 | Mark Astrachan | Stifel Nicolaus | $95.00 | $91.01 | 4.38% | -12.47% |
| Apr 10, 2024 | Mark Astrachan | Stifel Nicolaus | $94.00 | $87.65 | 7.24% | -13.39% |
| Apr 08, 2024 | Robert Ottenstein | Evercore ISI | $96.00 | $87.88 | 9.24% | -11.55% |
| Jan 29, 2024 | Olivia Tong | Raymond James | $91.00 | $83.72 | 8.69% | -16.15% |
| Jul 28, 2023 | Chris Casey | Wells Fargo | $81.00 | $75.62 | 7.11% | -25.37% |
| Jan 13, 2023 | - | J.P. Morgan | $86.00 | $77.61 | 10.81% | -20.76% |
The latest Colgate-Palmolive stock forecast, released on Jul 22, 2024 by Mark Astrachan from Stifel Nicolaus, set a price target of $105.00, which represents a 7.06% increase from the stock price at the time of the forecast ($98.08), and a -3.25% decrease from CL last price ($108.53).
Colgate-Palmolive Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 8 |
| Avg Price Target | - | $105.00 | $98.63 |
| Last Closing Price | $108.53 | $108.53 | $108.53 |
| Upside/Downside | -100.00% | -3.25% | -9.12% |
In the current month, the average price target of Colgate-Palmolive stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Colgate-Palmolive's last price of $108.53. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jul 29, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Jul 29, 2024 | Morgan Stanley | Overweight | Overweight | Hold |
| Jul 26, 2024 | HSBC | - | Hold | Downgrade |
| Jul 24, 2024 | Jefferies | - | Hold | Downgrade |
| Jul 22, 2024 | Cowen & Co. | - | Buy | Initialise |
| Jul 19, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
| Jul 18, 2024 | Evercore ISI | Outperform | Outperform | Hold |
| Jul 17, 2024 | Deutsche Bank | Buy | Buy | Hold |
| Jul 10, 2024 | Citigroup | Buy | Buy | Hold |
| Jun 24, 2024 | Exane BNP Paribas | - | Outperform | Initialise |
Colgate-Palmolive's last stock rating was published by Cowen & Co. on Jul 29, 2024. The company gave CL a "Buy" rating, the same as its previous rate.
Colgate-Palmolive Financial Forecast
Colgate-Palmolive Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $4.92B | $4.82B | $4.77B | $4.63B | $4.46B | - | $4.40B | $4.40B | $4.41B | $4.26B | $4.34B | $4.32B | $4.15B | $3.90B | $4.10B | $4.01B | $3.93B |
| Avg Forecast | $5.54B | $5.47B | $5.42B | $5.42B | $5.30B | $5.24B | $5.23B | $5.20B | $5.07B | $5.01B | $5.00B | $4.96B | $4.89B | $4.81B | $4.70B | $4.59B | $4.59B | $4.47B | $4.35B | $4.40B | $4.42B | $4.40B | $4.25B | $4.26B | $4.15B | $3.99B | $3.78B | $4.08B | $3.93B | $3.95B |
| High Forecast | $5.65B | $5.57B | $5.52B | $5.52B | $5.40B | $5.34B | $5.33B | $5.30B | $5.16B | $5.10B | $5.10B | $5.05B | $4.96B | $5.00B | $4.79B | $4.67B | $4.68B | $4.56B | $4.35B | $4.43B | $4.45B | $4.43B | $4.28B | $4.30B | $4.18B | $4.02B | $3.81B | $4.11B | $3.97B | $3.98B |
| Low Forecast | $5.49B | $5.41B | $5.37B | $5.37B | $5.25B | $5.19B | $5.18B | $5.15B | $5.02B | $4.96B | $4.95B | $4.91B | $4.80B | $4.72B | $4.65B | $4.54B | $4.55B | $4.43B | $4.35B | $4.37B | $4.39B | $4.37B | $4.22B | $4.24B | $4.12B | $3.96B | $3.75B | $4.05B | $3.91B | $3.92B |
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 4 | 7 | 11 | 5 | 9 | 5 | 4 | 4 | 8 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.03% | 1.04% | 1.01% | 1.00% | - | 1.00% | 1.00% | 1.00% | 1.00% | 1.02% | 1.04% | 1.04% | 1.03% | 1.01% | 1.02% | 1.00% |
Colgate-Palmolive's average Quarter revenue forecast for Dec 23 based on 7 analysts is $4.89B, with a low forecast of $4.80B, and a high forecast of $4.96B. CL's average Quarter revenue forecast represents a -0.44% decrease compared to the company's last Quarter revenue of $4.92B (Sep 23).
Colgate-Palmolive EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 4 | 7 | 11 | 5 | 9 | 5 | 4 | 4 | 8 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.03B | $974.00M | $1.04B | $1.78B | $947.00M | - | $998.00M | $426.00M | $946.00M | $1.05B | $1.05B | $988.00M | $1.05B | $984.00M | $995.00M | $964.00M | $875.00M |
| Avg Forecast | $1.47B | $1.45B | $1.44B | $1.44B | $1.41B | $1.39B | $1.39B | $1.38B | $1.35B | $1.33B | $1.33B | $1.04B | $1.30B | $1.28B | $1.25B | $948.20M | $1.22B | $1.01B | $1.16B | $862.00M | $426.00M | $922.05M | $1.05B | $1.03B | $975.00M | $918.49M | $927.77M | $981.55M | $964.00M | $862.50M |
| High Forecast | $1.50B | $1.48B | $1.47B | $1.47B | $1.44B | $1.42B | $1.42B | $1.41B | $1.37B | $1.36B | $1.36B | $1.25B | $1.32B | $1.33B | $1.27B | $1.14B | $1.24B | $1.22B | $1.16B | $1.03B | $511.20M | $1.11B | $1.26B | $1.24B | $1.17B | $1.10B | $1.11B | $1.18B | $1.16B | $1.03B |
| Low Forecast | $1.46B | $1.44B | $1.43B | $1.43B | $1.40B | $1.38B | $1.38B | $1.37B | $1.33B | $1.32B | $1.32B | $834.42M | $1.28B | $1.25B | $1.24B | $758.56M | $1.21B | $811.40M | $1.16B | $689.60M | $340.80M | $737.64M | $841.60M | $827.00M | $780.00M | $734.79M | $742.22M | $785.24M | $771.20M | $690.00M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.80% | 0.78% | 1.09% | 1.46% | 0.93% | - | 1.16% | 1.00% | 1.03% | 1.00% | 1.01% | 1.01% | 1.15% | 1.06% | 1.01% | 1.00% | 1.01% |
7 analysts predict CL's average Quarter EBITDA for Dec 23 to be $1.30B, with a high of $1.32B and a low of $1.28B. This is 26.49% upper than Colgate-Palmolive's previous annual EBITDA (Sep 23) of $1.03B.
Colgate-Palmolive Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 4 | 7 | 11 | 5 | 9 | 5 | 4 | 4 | 8 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $708.00M | $502.00M | $372.00M | $43.00M | $618.00M | - | $559.00M | $188.00M | $634.00M | $703.00M | $681.00M | $647.00M | $698.00M | $635.00M | $715.00M | $643.00M | $578.00M |
| Avg Forecast | $890.36M | $858.86M | $880.47M | $847.29M | $828.18M | $798.45M | $806.45M | $765.09M | $752.82M | $728.37M | $715.60M | $676.39M | $701.44M | $660.46M | $614.32M | $614.90M | $629.68M | $679.74M | $586.01M | $559.00M | $148.00M | $617.95M | $703.00M | $672.38M | $638.49M | $608.26M | $598.71M | $705.34M | $643.00M | $569.74M |
| High Forecast | $912.14M | $879.87M | $902.01M | $868.02M | $848.44M | $817.98M | $826.18M | $783.81M | $771.24M | $736.65M | $733.10M | $811.67M | $717.95M | $676.97M | $629.34M | $737.88M | $645.08M | $815.69M | $586.01M | $670.80M | $177.60M | $741.54M | $843.60M | $806.86M | $766.18M | $729.91M | $718.46M | $846.41M | $771.60M | $683.69M |
| Low Forecast | $878.86M | $847.77M | $869.10M | $836.35M | $817.49M | $788.14M | $796.04M | $755.22M | $743.10M | $720.10M | $706.36M | $541.11M | $693.18M | $643.94M | $606.38M | $491.92M | $621.55M | $543.80M | $586.01M | $447.20M | $118.40M | $494.36M | $562.40M | $537.90M | $510.79M | $486.61M | $478.97M | $564.27M | $514.40M | $455.79M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.07% | 0.82% | 0.60% | 0.07% | 0.91% | - | 1.00% | 1.27% | 1.03% | 1.00% | 1.01% | 1.01% | 1.15% | 1.06% | 1.01% | 1.00% | 1.01% |
Colgate-Palmolive's average Quarter net income forecast for Dec 23 is $701.44M, with a range of $693.18M to $717.95M. CL's average Quarter net income forecast represents a -0.93% decrease compared to the company's last Quarter net income of $708.00M (Sep 23).
Colgate-Palmolive SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 4 | 7 | 11 | 5 | 9 | 5 | 4 | 4 | 8 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.82B | $1.77B | $1.76B | $1.63B | $1.63B | - | $1.64B | $1.60B | $1.64B | $1.57B | $1.60B | $1.63B | $1.52B | $1.40B | $1.47B | $1.41B | $1.43B |
| Avg Forecast | $2.00B | $1.97B | $1.95B | $1.95B | $1.91B | $1.89B | $1.88B | $1.88B | $1.83B | $1.81B | $1.80B | $1.99B | $1.76B | $1.74B | $1.69B | $1.81B | $1.66B | $1.75B | $1.57B | $1.64B | $1.60B | $1.59B | $1.57B | $1.58B | $1.61B | $1.32B | $1.32B | $1.45B | $1.41B | $1.41B |
| High Forecast | $2.04B | $2.01B | $1.99B | $1.99B | $1.95B | $1.92B | $1.92B | $1.91B | $1.86B | $1.84B | $1.84B | $2.38B | $1.79B | $1.80B | $1.72B | $2.17B | $1.69B | $2.10B | $1.57B | $1.97B | $1.92B | $1.91B | $1.88B | $1.90B | $1.93B | $1.59B | $1.58B | $1.74B | $1.69B | $1.69B |
| Low Forecast | $1.98B | $1.95B | $1.93B | $1.93B | $1.89B | $1.87B | $1.87B | $1.86B | $1.81B | $1.79B | $1.79B | $1.59B | $1.73B | $1.70B | $1.68B | $1.44B | $1.64B | $1.40B | $1.57B | $1.31B | $1.28B | $1.28B | $1.25B | $1.27B | $1.29B | $1.06B | $1.05B | $1.16B | $1.13B | $1.13B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.05% | 1.04% | 0.97% | 0.99% | 0.93% | - | 1.00% | 1.00% | 1.03% | 1.00% | 1.01% | 1.01% | 1.15% | 1.06% | 1.01% | 1.00% | 1.01% |
Colgate-Palmolive's average Quarter SG&A projection for Dec 23 is $1.76B, based on 7 Wall Street analysts, with a range of $1.73B to $1.79B. The forecast indicates a -3.20% fall compared to CL last annual SG&A of $1.82B (Sep 23).
Colgate-Palmolive EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 4 | 7 | 11 | 5 | 9 | 5 | 4 | 4 | 8 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.86 | $0.61 | $0.45 | $0.05 | $0.74 | - | $0.67 | $0.22 | $0.75 | $0.83 | $0.80 | $0.76 | $0.81 | $0.74 | $0.83 | $0.75 | $0.67 |
| Avg Forecast | $1.08 | $1.04 | $1.07 | $1.03 | $1.01 | $0.97 | $0.98 | $0.93 | $0.91 | $0.88 | $0.87 | $0.81 | $0.85 | $0.80 | $0.75 | $0.70 | $0.76 | $0.73 | $0.71 | $0.74 | $0.79 | $0.80 | $0.80 | $0.79 | $0.76 | $0.70 | $0.70 | $0.73 | $0.73 | $0.70 |
| High Forecast | $1.11 | $1.07 | $1.10 | $1.05 | $1.03 | $0.99 | $1.00 | $0.95 | $0.94 | $0.89 | $0.89 | $0.83 | $0.87 | $0.82 | $0.76 | $0.72 | $0.78 | $0.75 | $0.71 | $0.75 | $0.79 | $0.80 | $0.81 | $0.80 | $0.77 | $0.71 | $0.70 | $0.74 | $0.73 | $0.71 |
| Low Forecast | $1.07 | $1.03 | $1.06 | $1.02 | $0.99 | $0.96 | $0.97 | $0.92 | $0.90 | $0.87 | $0.86 | $0.80 | $0.84 | $0.78 | $0.74 | $0.69 | $0.75 | $0.72 | $0.71 | $0.74 | $0.78 | $0.79 | $0.79 | $0.78 | $0.76 | $0.70 | $0.69 | $0.73 | $0.72 | $0.69 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.07% | 0.82% | 0.64% | 0.07% | 1.01% | - | 0.90% | 0.28% | 0.94% | 1.04% | 1.01% | 0.99% | 1.15% | 1.06% | 1.13% | 1.03% | 0.96% |
According to 7 Wall Street analysts, Colgate-Palmolive's projected average Quarter EPS for Dec 23 is $0.85, with a low estimate of $0.84 and a high estimate of $0.87. This represents a -0.98% decrease compared to CL previous annual EPS of $0.86 (Sep 23).
Colgate-Palmolive Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| EL | Estée Lauder Companies | $90.07 | $179.47 | 99.26% | Hold |
| CHD | Church & Dwight | $105.49 | $111.00 | 5.22% | Buy |
| KMB | Kimberly-Clark | $148.05 | $144.15 | -2.63% | Hold |
| UL | Unilever | $65.46 | $59.00 | -9.87% | Buy |
| CLX | Clorox | $164.82 | $146.67 | -11.01% | Hold |
| PG | Procter & Gamble | $175.47 | $156.05 | -11.07% | Buy |
| CL | Colgate-Palmolive | $108.53 | $90.75 | -16.38% | Buy |
CL Forecast FAQ
Is Colgate-Palmolive a good buy?
Yes, according to 18 Wall Street analysts, Colgate-Palmolive (CL) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 12 'Buy' recommendations, accounting for 66.67% of CL's total ratings.
What is CL's price target?
Colgate-Palmolive (CL) average price target is $90.75 with a range of $80 to $107, implying a -16.38% from its last price of $108.53. The data is based on 18 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Colgate-Palmolive stock go up soon?
According to Wall Street analysts' prediction for CL stock, the company can go down by -16.38% (from the last price of $108.53 to the average price target of $90.75), down by -1.41% based on the highest stock price target, and down by -26.29% based on the lowest stock price target.
Can Colgate-Palmolive stock reach $200?
CL's average twelve months analyst stock price target of $90.75 does not support the claim that Colgate-Palmolive can reach $200 in the near future.
What are Colgate-Palmolive's analysts' financial forecasts?
Colgate-Palmolive's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $20.97B (high $21.36B, low $20.76B), average EBITDA is $5.58B (high $5.68B, low $5.52B), average net income is $3.2B (high $3.28B, low $3.16B), average SG&A $7.56B (high $7.7B, low $7.48B), and average EPS is $3.88 (high $3.98, low $3.83). CL's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $21.85B (high $22.27B, low $21.64B), average EBITDA is $5.81B (high $5.92B, low $5.76B), average net income is $3.48B (high $3.56B, low $3.43B), average SG&A $7.88B (high $8.03B, low $7.8B), and average EPS is $4.22 (high $4.32, low $4.17).
Did the CL's actual financial results beat the analysts' financial forecasts?
Based on Colgate-Palmolive's last annual report (Dec 2022), the company's revenue was $17.97B, beating the average analysts forecast of $17.81B by 0.86%. Apple's EBITDA was $4.88B, beating the average prediction of $4.26B by 14.68%. The company's net income was $1.78B, missing the average estimation of $2.45B by -27.27%. Apple's SG&A was $6.56B, missing the average forecast of $6.62B by -0.81%. Lastly, the company's EPS was $2.13, missing the average prediction of $2.95 by -27.81%. In terms of the last quarterly report (Sep 2023), Colgate-Palmolive's revenue was $4.92B, beating the average analysts' forecast of $4.81B by 2.10%. The company's EBITDA was $1.03B, missing the average prediction of $1.28B by -19.63%. Colgate-Palmolive's net income was $708M, beating the average estimation of $660.46M by 7.20%. The company's SG&A was $1.82B, beating the average forecast of $1.74B by 5.01%. Lastly, the company's EPS was $0.86, beating the average prediction of $0.802 by 7.26%